## Clinical Diagnosis The presentation of fever, headache, petechial rash, and gram-negative diplococci in CSF is diagnostic of **meningococcal meningitis** caused by *Neisseria meningitidis*. ## Drug of Choice **Key Point:** Ceftriaxone (2 g IV every 12 hours) is the current first-line agent for bacterial meningitis worldwide, including empiric coverage in India, because it achieves high CSF penetration and covers *N. meningitidis*, *Streptococcus pneumoniae*, and *Listeria monocytogenes* (when combined with ampicillin in older or immunocompromised patients). ## Why Ceftriaxone Over Penicillin? | Feature | Ceftriaxone | Penicillin G | |---------|-------------|-------------| | **CSF Penetration** | Excellent (20–30% of serum) | Moderate (5–10% of serum) | | **Spectrum** | Gram-negative cocci, gram-positive cocci | Gram-positive cocci only | | **Pneumococcal Coverage** | Includes penicillin-resistant strains | Limited against resistant strains | | **Meningitis Dosing** | 2 g IV Q12H (high-dose) | 4 MU IV Q4H | | **Current Guideline** | First-line (WHO, CDC, NACO) | Outdated for meningitis | **High-Yield:** *Neisseria meningitidis* is a gram-negative diplococcus (kidney-bean shaped) with a polysaccharide capsule. Cephalosporins penetrate the blood–brain barrier better than penicillins and are superior for CNS infections. ## Empiric Meningitis Coverage **Clinical Pearl:** In India, empiric meningitis regimens typically include: 1. **Ceftriaxone 2 g IV Q12H** (covers *N. meningitidis*, *S. pneumoniae*) 2. **+ Ampicillin 2 g IV Q4H** (if age >50 or immunocompromised, for *Listeria*) 3. **+ Vancomycin** (if penicillin-resistant *S. pneumoniae* suspected) Doxycycline or fluoroquinolones are alternatives only in penicillin/cephalosporin allergy. ## Mnemonic **CEF for CNS** — Cephalosporins (especially 3rd-generation like ceftriaxone) are the go-to for meningitis because of superior blood–brain barrier penetration.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.